Recursion Pharmaceuticals, Inc 10-K for FY2023
Recursion Pharmaceuticals, Inc. (RXRX)
10-K
2024-02-29
For: 2023-12-31
View Original
Added on
April 10, 2026
About this 10-K
Recursion Pharmaceuticals, Inc filed this 10-K on February 29, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $44.58M
- up 11.9% from $39.84M a year earlier
- Net loss
- $328.07M
- compared with a net loss of $239.48M a year earlier
- Diluted EPS
- -$1.58
- compared with -$1.36 a year earlier